8th Annual Translational Microbiome Conference

8th Annual Translational Microbiome Conference is dedicated to the potential for translational interventions in microbiome research. The following therapeutic areas of research will be discussed:

• Obesity and Type 2 diabetes
• Women`s Health
• Immunology and the Impact of C. diffiicle Infections
• Pulmonology and COPD
• Periodontal Disease
• Dermatology

8th Annual Translational Microbiome Conference covers topics such as:

• The applicability of animal microbiome models to the human microbiome
• The need for standardization and harmonization of research protocols
• How the FDA will and should regulate therapeutics containing live spores
• The business model for microbiome based therapeutics
• Data needs across multiple domains

8th Annual Translational Microbiome Conference brings together Directors, VPs, Scientists, Heads and Professors from biotech companies, Academic Institutions, venture capitalists and pharma companies involved in:

• NGS (Next Generation Sequencing)
• Microbiome / Microbiota basic research
• Autoimmune Disease Therapeutics
• Molecular Diagnostics
• Metabolic disease, Obesity, Diabetes
• Infectious Diseases
• Genomics
• Genotyping
• Biomarkers
• Genomic Profiling
• Bioinformatics
• Immunology Innate or Adaptive Immunity
• Data Analysis
• Data Management
• Diagnostic & Clinical Applications
• Molecular Biology
• Vaccines
• Prenantal Diagnostics
• Food / Nutrition Science
• Microbiology
• Venture Capitalists
• Gut-Brain Axis Researchers
• Academic Licensing or Tech Transfer Officers
• Biotech Entrepreneurs

8th Annual Translational Microbiome Conference might be held in United States in Apr 2022 (TBD).